Bellwether Trials in Taxotere Lawsuit to Begin May 2019
On June 13th, the federal court overseeing thousands of Taxotere lawsuits ordered that bellwether trials will begin in May 2019. Taxotere (docetaxel) is a chemotherapy drug manufactured by Sanofi-Aventis. Recently, over 8,700 lawsuits have been filed alleging that alopecia (hair loss) caused by this drug is far more likely to be permanent compared to equally-effective alternative medications. All federally filed complaints have been centralized to proceed together in the Eastern District of Louisiana under Judge Jane T. Milazzo.